Concord Biotech Ltd.

CONCORDBIO

₹1543.6

1.35% (20.6)

Market Cap

₹16,107 Cr.

P/E

49.37

About

Concord Biotech Limited, an India-based biopharmaceutical company, is a major global player in fermentation-based APIs within Immunosuppressants and oncology. It holds a significant market share world… Read more

Concord Biotech Limited, an India-based biopharmaceutical company, is a major global player in… Read more

Low

1327

52W Range

High

2664

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
Sales Growth

Unable to calculate due to limited data

Market Share

20 %

(as of Jun 24)

Historic

Fermentation Based API Products - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

US DMF Filings (.)
Source
Europe DMF Filings (.)
Source
Global DMFs filed (.)
Source
Total reactor capacity (kL)
Source
Japan DMF Filings (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Concord Biotech Ltd. Business

What does Concord Biotech do?

Concord Biotech Limited, an India-based biopharmaceutical company, specializes in fermentation-based APIs for Immunosuppressants and oncology. It has a strong global presence in the US, Europe, and Japan with an expanding formulation business.

Who are the competitors of Concord Biotech?

Concord Biotech major competitors are Biocon, Guj. Themis Biosyn, Advanced Enzyme, Fermenta Biotech, Natco Pharma, Alembic Pharma, Caplin Point Lab.
Market Cap of Concord Biotech is ₹16,107 Crs.
While the median market cap of its peers are ₹14,194 Crs.

Is Concord Biotech financially stable compared to its competitors?

Concord Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation		Mar Jun Sep Dec	Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Concord Biotech Ltd.

View The Discussion On Valuepickr

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Concord Biotech Ltd.